(1 - 19 from 41
)
Professor Klaus Dugi | EuropaWire.eu
news.europawire.eu
Professor Klaus Dugi, Corporate Senior Vice President Medicine, Boehringer Ingelheim. For media outside of the US, the UK & Canada only ...
Boehringer Ingelheim and Eli Lilly and Company announce positive...
investor.lilly.com
Klaus Dugi , Corporate Senior Vice President Medicine, Boehringer Ingelheim. " Many patients with type 2 diabetes are not meeting their blood ...
Boehringer Ingelheim announced new data analyses show positive...
news.europawire.eu
Phone + Fax + ###. Professor Klaus Dugi, Corporate Senior Vice President Medicine, Boehringer Ingelheim.
Boehringer-Ingelheim - Still Relying on RE-LY? | Levin Papantonio -...
www.levinlaw.com
The argument from Klaus Dugi, BI's corporate senior vice president, is that the company's own studies “have demonstrated that Pradaxa® offers ...
sorted by relevance / date